The document discusses the various types of routine monitoring visits in clinical research, emphasizing the roles and tasks of Clinical Research Associates (CRAs) during these visits. It contrasts traditional and risk-based monitoring strategies, highlighting that the latter is more efficient by focusing on specific site weaknesses instead of a one-size-fits-all approach. The importance of preparation, communication, and follow-up letters in the monitoring process is also outlined to ensure that clinical trials run smoothly and comply with guidelines.
Related topics: